Farnum Rhonda
SEC CIK 1898490 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | SVP, Comm, Medical Affairs | 0 | — | $2.12M | 43 | 2021-12-14 | 2026-09-23 |
Most active insiders at TBPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samaha Eli | 10% | — | $5.91M |
| 2 | BROSHY ERAN | Dir | — | $2.47M |
| 3 | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | — | $1.46M |
| 4 | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | — | — |
| 5 | Grimaud Brett A. | SVP, GEN COUNSEL AND Sec | — | — |
| 6 | Sawaf Aziz | SVP, CFO | — | — |
| 7 | GRAY SUSANNAH | Dir | — | — |
| 8 | O'Connor Donal | Dir | — | — |
| 9 | Smaldone Alsup Laurie | Dir | — | — |
| 10 | Winningham Rick E | CEO, Dir | — | — |
Transactions 43
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-24 20:21 | 2026-09-23 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | D - Sale to Iss | — | -213.5K | 0 | -100% | — |
| MT | 2026-09-17 17:52 | 2026-09-15 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $17.03 | -13.3K | 213.5K | -6% | -$226.8K |
| 2026-08-24 18:00 | 2026-08-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $16.95 | -5,667 | 226.8K | -2% | -$96.1K | |
| MT | 2026-06-17 19:56 | 2026-06-15 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $16.39 | -13.3K | 232.5K | -5% | -$218.2K |
| 2026-05-22 18:18 | 2026-05-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $16.55 | -5,678 | 245.8K | -2% | -$94.0K | |
| 2026-04-03 18:03 | 2026-04-01 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | A - Grant | $0.00 | +18.8K | 251.4K | +8% | $0 | |
| M | 2026-03-18 | 2026-03-16 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $13.96 | -31.1K | 240.5K | -11% | -$433.7K |
| 2026-02-24 | 2026-02-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $19.66 | -13.9K | 263.8K | -5% | -$273.8K | |
| M | 2025-12-05 | 2025-12-03 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $18.75 | -31.1K | 277.7K | -10% | -$582.5K |
| 2025-11-24 | 2025-11-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $17.90 | -9,060 | 308.8K | -3% | -$162.2K | |
| 2025-08-22 | 2025-08-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $13.39 | -9,096 | 317.8K | -3% | -$121.8K | |
| M | 2025-07-16 | 2025-07-14 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $11.39 | -10.0K | 330.9K | -3% | -$113.9K |
| 2025-06-04 | 2025-06-02 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $11.00 | -24.0K | 336.9K | -7% | -$264.0K | |
| 2025-05-22 | 2025-05-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.45 | -9,120 | 360.9K | -2% | -$86.2K | |
| 2025-04-23 | 2025-04-21 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $9.00 | -4,000 | 370.0K | -1% | -$36.0K | |
| 2025-03-04 | 2025-02-28 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | A - Grant | $0.00 | +75.0K | 374.0K | +25% | $0 | |
| 2025-02-24 | 2025-02-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.66 | -15.8K | 299.0K | -5% | -$152.7K | |
| 2025-02-24 | 2025-02-10 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | A - Grant | $0.00 | +5,283 | 314.8K | +2% | $0 | |
| 2025-01-23 | 2025-01-21 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $9.00 | -4,000 | 309.6K | -1% | -$36.0K | |
| 2024-11-22 | 2024-11-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.97 | -9,178 | 313.6K | -3% | -$91.5K | |
| 2024-11-13 | 2024-11-11 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $9.00 | -4,000 | 322.7K | -1% | -$36.0K | |
| 2024-08-22 | 2024-08-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $8.22 | -9,222 | 326.7K | -3% | -$75.8K | |
| 2024-07-12 | 2024-07-10 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $9.00 | -4,000 | 336.0K | -1% | -$36.0K | |
| 2024-05-22 | 2024-05-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.10 | -9,268 | 340.0K | -3% | -$84.3K | |
| 2024-04-04 | 2024-04-02 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | A - Grant | $0.00 | +37.5K | 349.2K | +12% | $0 | |
| 2024-02-22 | 2024-02-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $8.92 | -18.2K | 313.0K | -6% | -$162.5K | |
| 2024-02-22 | 2024-02-22 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $8.71 | -1,254 | 311.7K | -0.4% | -$10.9K | |
| 2023-11-22 | 2023-11-21 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $10.29 | -1,378 | 331.2K | -0.4% | -$14.2K | |
| 2023-11-22 | 2023-11-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $10.37 | -7,982 | 332.6K | -2% | -$82.8K | |
| 2023-08-24 | 2023-08-22 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $9.47 | -1,807 | 340.6K | -0.5% | -$17.1K | |
| 2023-08-22 | 2023-08-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.70 | -10.5K | 342.4K | -3% | -$101.5K | |
| 2023-06-12 | 2023-06-08 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $11.13 | -1,790 | 352.8K | -0.5% | -$19.9K | |
| 2023-05-23 | 2023-05-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $11.21 | -5,567 | 354.6K | -2% | -$62.4K | |
| 2023-03-13 | 2023-03-09 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $10.20 | -4,000 | 360.2K | -1% | -$40.8K | |
| 2023-03-03 | 2023-03-01 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | A - Grant | $0.00 | +75.0K | 364.2K | +26% | $0 | |
| 2023-02-22 | 2023-02-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $10.44 | -7,119 | 289.2K | -2% | -$74.3K | |
| 2022-11-22 | 2022-11-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $10.85 | -23.3K | 296.3K | -7% | -$252.5K | |
| 2022-08-23 | 2022-08-19 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.34 | -10.4K | 319.6K | -3% | -$97.3K | |
| 2022-05-24 | 2022-05-23 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $8.93 | -1,081 | 330.0K | -0.3% | -$9,653 | |
| 2022-05-24 | 2022-05-20 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $8.74 | -2,200 | 331.1K | -0.7% | -$19.2K | |
| 2022-03-02 | 2022-02-28 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | S - Sale | $10.16 | -2,356 | 333.3K | -0.7% | -$23.9K | |
| 2022-02-23 | 2022-02-18 | TBPH | Theravance Biopharma, Inc. | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.61 | -11.8K | 335.6K | -3% | -$113.6K | |
| 2021-12-16 | 2021-12-14 | TBPH | Theravance Biopharma, Inc. | SVP, Comm, Medical Affairs | A - Grant | $0.00 | +27.5K | 347.5K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations